Direct-to-consumer advertising has become a major tactic for pharmaceutical brand marketing, accounting for an estimated 12% of 2003’s overall promotional spending, according to pharmaceutical market researchers IMS Health Inc.
Beyond the obvious examples such as Pfizer’s Viagra and AstraZeneca’s Nexium
Network
